These final results, together with a former report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the concept of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-conn